Gene expression profile in human induced pluripotent stem cells: Chondrogenic differentiation in vitro, part A

Suchorska,Wiktoria  Maria; Augustyniak,Ewelina; Richter,Magdalena; Trzeciak,Tomasz

doi:10.3892/mmr.2017.6334

Gene expression profile in human induced pluripotent stem cells: Chondrogenic differentiation in vitro, part A

Authors:
- Wiktoria Maria Suchorska
- Ewelina Augustyniak
- Magdalena Richter
- Tomasz Trzeciak
View Affiliations

Affiliations: Radiobiology Laboratory, Greater Poland Cancer Centre, 61‑866 Poznan, Poland, Department of Orthopedics and Traumatology, Poznan University of Medical Sciences, 61‑545 Poznan, Poland
Published online on: March 16, 2017 https://doi.org/10.3892/mmr.2017.6334
Pages: 2387-2401
Copyright: © Suchorska et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Human induced pluripotent stem cells (hiPSCs) offer promise in regenerative medicine, however more data are required to improve understanding of key aspects of the cell differentiation process, including how specific chondrogenic processes affect the gene expression profile of chondrocyte‑like cells and the relative value of cell differentiation markers. The main aims of the present study were as follows: To determine the gene expression profile of chondrogenic-like cells derived from hiPSCs cultured in mediums conditioned with HC‑402‑05a cells or supplemented with transforming growth factor β3 (TGF‑β3), and to assess the relative utility of the most commonly used chondrogenic markers as indicators of cell differentiation. These issues are relevant with regard to the use of human fibroblasts in the reprogramming process to obtain hiPSCs. Human fibroblasts are derived from the mesoderm and thus share a wide range of properties with chondrocytes, which also originate from the mesenchyme. Thus, the exclusion of dedifferentiation instead of chondrogenic differentiation is crucial. The hiPSCs were obtained from human primary dermal fibroblasts during a reprogramming process. Two methods, both involving embryoid bodies (EB), were used to obtain chondrocytes from the hiPSCs: EBs formed in a chondrogenic medium supplemented with TGF‑β3 (10 ng/ml) and EBs formed in a medium conditioned with growth factors from HC‑402‑05a cells. Based on immunofluorescence and reverse transcription‑quantiative polymerase chain reaction analysis, the results indicated that hiPSCs have the capacity for effective chondrogenic differentiation, in particular cells differentiated in the HC‑402‑05a‑conditioned medium, which present morphological features and markers that are characteristic of mature human chondrocytes. By contrast, cells differentiated in the presence of TGF‑β3 may demonstrate hypertrophic characteristics. Several genes [paired box 9, sex determining region Y-box (SOX) 5, SOX6, SOX9 and cartilage oligomeric matrix protein] were demonstrated to be good markers of early hiPSC chondrogenic differentiation: Insulin‑like growth factor 1, Tenascin‑C, and β‑catenin were less valuable. These observations provide valuable data on the use of hiPSCs in cartilage tissue regeneration.

View Figures

View References

1	Liu T, Li Q, Wang S, Chen C and Zheng J: Transplantation of ovarian granulosa-like cells derived from human induced pluripotent stem cells for the treatment of murine premature ovarian failure. Mol Med Rep. 13:5053–5058. 2016.PubMed/NCBI
2	Cao B, Li Z, Peng R and Ding J: Effects of cell-cell contact and oxygen tension on chondrogenic differentiation of stem cells. Biomaterials. 64:21–32. 2015. View Article : Google Scholar : PubMed/NCBI
3	Lach M, Trzeciak T, Richter M, Pawlicz J and Suchorska WM: Directeddifferentiation of induced pluripotent stem cells into chondrogenic lineages for articular cartilage treatment. J Tissue Eng. 5:20417314145527012014. View Article : Google Scholar : PubMed/NCBI
4	Ren Y, Deng CL, Wan WD, Zheng JH, Mao GY and Yang SL: Suppresive effects of induced pluripotent stem cell-conditioned medium in in vitro hypertrophic scarring fibroblast activation. Mol Med Rep. 11:2471–2476. 2015.PubMed/NCBI
5	Chen FH and Tuan RS: Mesenchymal stem cells in arthritic diseases. Arthritic Res Ther. 10:2232008. View Article : Google Scholar
6	Kulcenty K, Wróblewska J, Mazurek S, Liszewska E and Jaworski J: Molecular mechanisms of induced pluripotency. Contemp Oncol (Pozn). 19:A22–A29. 2015.PubMed/NCBI
7	Suchorska WM, Augustyniak E and Łukjanow M: Genetic stability of pluripotent stem cells during anti-cancer therapies. Exp Ther Med. 11:695–702. 2016.PubMed/NCBI
8	Lee J, Taylor SE, Smeriglio P, Lai J, Maloney WJ, Yang F and Bhutani N: Early induction of a prechondrogenic population allows efficient generation of stable chondrocytes from human induced pluripotent stem cells. FASEB J. 29:3399–3410. 2015. View Article : Google Scholar : PubMed/NCBI
9	Ye J, Hong J and Ye F: Reprogramming rat embryonic fibroblasts into induced pluripotent stem cells using transposon vectors and their chondrogenic differentiation in vitro. Mol Med Rep. 11:989–994. 2015.PubMed/NCBI
10	Fu C, Yan Z, Xu H, Zhang C, Zhang Q, Wei A, Yang X and Wang Y: Isolation, identification and differentiation of human embryonic cartilage stem cells. Cell Biot Int. 39:777–787. 2015. View Article : Google Scholar
11	Oldershaw RA, Baxter MA, Lowe ET, Bates N, Grady LM, Soncin F, Brison DR, Hardingham TE and Kimber SJ: Directed differentiation of human embryonic stem cells toward chondrocytes. Nat Biotechnol. 28:1187–1194. 2010. View Article : Google Scholar : PubMed/NCBI
12	Toh WS and Cao T: Derivation of chondrogenic cells from human embryonic stem cells for cartilage tissue engineering. Methods Mol Biol. Jul 12–2014.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
13	Mardani M, Hashemibeni B, Ansar MM, ZarkeshEsfahani SH, Kazemi M, Goharian V, Esmaeili N and Esfandiary E: Comparison between chondrogenic markers of differentiated chondrocytes from adipose deived stem cells and articular chondrocytes in vitro. Iran J Basic Med Sci. 16:763–773. 2013.PubMed/NCBI
14	Lee HJ, Choi BH, Min BH and Park SR: Changes in Surface markers of human mesenchymal stem cells during the chondrogenic differentiation and dedifferentiation processes in vitro. Arthritis Rheum. 60:2325–2332. 2009. View Article : Google Scholar : PubMed/NCBI
15	Augustyniak E, Trzeciak T, Richter M, Kaczmarczyk J and Suchorska W: The role of growth factors in stem cell-directed chondrogenesis: A real hope for damaged cartilage regeneration. Int Orthop. 39:995–1003. 2015. View Article : Google Scholar : PubMed/NCBI
16	Augustyniak E, Suchorska WM, Trzeciak T and Richter M: Gene expression profile in human induced pluripotent stem cells: Chondrogenic differentiation in vitro, part B. Mol Med Rep. 15:2402–2414. 2017.
17	Wróblewska J: A new method to generate human induced pluripotent stem cells (iPS) and the role of the protein KAP1 in epigenetic regulation of self-renewal. PhD dissertation. Poznan University of Medical Sciences. http://www.wbc.poznan.pl/Content/373798/index.pdf2015.
18	Suchorska WM, Lach MS, Richter M, Kaczmarczyk J and Trzeciak T: Bioimaging: An useful tool to monitor differentiation of human embryonic stem cells into chondrocytes. Ann Biomed Eng. 44:1845–1859. 2016. View Article : Google Scholar : PubMed/NCBI
19	Nejadnik H, Diecke S, Lenkov OD, Chapelin F, Doing J, Tong X, Derugin N, Chan RC, Gaur A, Yang F, et al: Improved approach for chondrogenic differentiation of human induced pluripotent stem cells. Stem Cell Rev. 11:242–253. 2015. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta (CT)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Rodrigo I, Hill RE, Balling R, Münsterberg A and Imai K: Pax1 and Pax9 activate Bapx1 to induce chondrogenic differentiation in the sclerotome. Development. 130:473–482. 2003. View Article : Google Scholar : PubMed/NCBI
22	Blake JA and Ziman MR: Pax genes: Regulators of lineage specification and progenitor cell maintenance. Development. 141:737–751. 2014. View Article : Google Scholar : PubMed/NCBI
23	Singh P and Schwarzbauer JE: Fibronectin and stem cel differentiation-lessons from chondrogenesis. J Cell Sci. 125:3703–3712. 2012. View Article : Google Scholar : PubMed/NCBI
24	Gigout A, Jolicoeur M, Nelea M, Raynal N, Farndale R and Buschmann MD: Chondrocyte aggregation in suspension culture is GFOGER-GPP- and beta1 integrin-dependent. J Biol Chem. 283:31522–31530. 2008. View Article : Google Scholar : PubMed/NCBI
25	Fang J and Hall BK: Differential expression of neural cell adhesion molecule (NCAM) during osteogenesis and secondary chondrogenesis in the embryonic chick. Int J Dev Biol. 39:519–528. 1995.PubMed/NCBI
26	Nakatani K, Tanaka H, Ikeda K, Sakabe M, Kadoya H, Seki S, Kaneda K and Nakajima Y: Expression of NCAM in activated portal fibroblasts during regeneration of the rat liver after partial hepatectomy. Arch Histol Cytol. 69:61–72. 2006. View Article : Google Scholar : PubMed/NCBI
27	Francavilla C, Loeffler S, Piccini D, Kren A, Christofori G and Cavallaro U: Neural cel adhesion molecule regulates the cellular response to fibroblast growth factor. J Cell Sci. 120:4388–4394. 2007. View Article : Google Scholar : PubMed/NCBI
28	Rainbow RS, Kwon H and Zeng L: The role of Nkx3. 2 in chondrogenesis. Front Biol (Beijing). 9:376–381. 2014. View Article : Google Scholar : PubMed/NCBI
29	Kawato Y, Hirao M, Ebina K, Shi K, Hashimoto J, Honjo Y, Yoshikawa H and Myoui A: Nkx3.2 promotes primary chondrogenic differentiation by upregulating Col2a1transcription. PLoS One. 7:e347032012. View Article : Google Scholar : PubMed/NCBI
30	Choi SW, Jeong DU, Kim JA, Lee B, Joeng KS, Long F and Kim DW: Indian Hedgehog signaling triggers Nkx3.2 protein degradation during chondrocyte maturation. Biochem J. 443:789–798. 2012. View Article : Google Scholar : PubMed/NCBI
31	Liu CF and Lefebvre V: The transcription factors SOX9 and SOX5/SOX6 cooperate genome-wide through super-enhancer to drive chondrogenesis. Nucleic Acids Res. 43:8183–8203. 2015. View Article : Google Scholar : PubMed/NCBI
32	Han Y and Lefebvre V: L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol Cell Biol. 28:4999–5013. 2008. View Article : Google Scholar : PubMed/NCBI
33	Yamamizu K, Schlessinger D and Ko MS: SOX9 accelerates ESC differentiation to three germ layer lineages by repressing SOX2 expression through P21 (WAF1/CIP1). Development. 141:4254–4266. 2014. View Article : Google Scholar : PubMed/NCBI
34	Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, Zhang Z, Deng JM, Taketo MM, Nakamura T, Behringer RR, et al: Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev. 18:1072–1087. 2004. View Article : Google Scholar : PubMed/NCBI
35	Liao J, Hu N, Zhou N, Lin L, Zhao C, Yi S, Fan T, Bao W, Liang X, Chen H, et al: Sox9 potentiates BMP-2 induced chondrogenic differentiation and inhibits BMP-induced osteogenic differentiation. PLoS One. 9:e890252014. View Article : Google Scholar : PubMed/NCBI
36	Hamda T, Sakai T, Hiraiwa H, Nakashima M, Ono Y, Mitsuyama H and Ishiguro N: Surface markers and gene expression to characterize the differentiation of monolayer expanded human articular chondrocytes. Nagoya J Med Sci. 75:101–111. 2013.PubMed/NCBI
37	Sivan SS, Wachtel E and Roughley P: Structure, function, aging and turnover of aggrecan in the invertebral disc. Biochim Biophys Acta. 1840:3181–3189. 2014. View Article : Google Scholar : PubMed/NCBI
38	Kiani C, Chen L, Wu YJ, Yee AJ and Yang BB: Structure and function of aggrecan. Cell Res. 12:19–32. 2002. View Article : Google Scholar : PubMed/NCBI
39	Meng Q, Long X, Deng M, Cai H and Li J: The expressions of IGF-1, BMP-2 and TGF-β1 in cartilage of condylar hyperplasia. J Oral Rehabil. 38:34–40. 2011. View Article : Google Scholar : PubMed/NCBI
40	Agriogiannis GD, Sifakis S, Patsouris ES and Konstantinidou AE: Insulin-like growth factors in embryonic fetal growth and skeletal development (Review). Mol Med Rep. 10:579–584. 2014.PubMed/NCBI
41	Fujita T, Azuma Y, Fukuyama R, Hattori Y, Yoshida C, Koida M, Ogita K and Komori T: Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with P13K-Akt signaling. J Cell Biol. 166:85–95. 2004. View Article : Google Scholar : PubMed/NCBI
42	Guntur AR and Rosen CJ: IGF-1 regulation of key signaling pathway in bone. Bonekey Rep. 2:4372013. View Article : Google Scholar : PubMed/NCBI
43	Huang YH, Chin CC, Ho HN, Chou CK, Shen CN, Kuo HC, Wu TJ, Wu YC, Hung YC, Chang CC and Ling TY: Pluripotency of mouse spermatogonial stem cells maintained by IGF-dependent pathway. FASEB J. 23:2076–2087. 2009. View Article : Google Scholar : PubMed/NCBI
44	Nicoll SB, Barak O, Csóka AB, Bhatnagar RS and Stern R: Hyaluronidases and CD44 undergo differential modulating during chondrogenesis. Biochem Biophys Res Commun. 292:819–825. 2002. View Article : Google Scholar : PubMed/NCBI
45	Takahashi N, Knudson CB, Thankamony S, Ariyoshi W, Mellor L, Im HJ and Knudson W: Induction of CD44 cleavage in articular chondrocytes. Arthritis Rheum. 62:1338–1348. 2010. View Article : Google Scholar : PubMed/NCBI
46	Quintanilla RH Jr, Asprer JC, Vaz C, Tanavde V and Lakshmipathy U: CD44 is a negative cell surface marker for pluripotent stem cell identification during human fibroblast reprogramming. PLoS One. 9:e854192014. View Article : Google Scholar : PubMed/NCBI
47	Acharya PS, Majumdar S, Jacob M, Hayden J, Mrass P, Weninger W, Assoian RK and Puré E: Fibroblast migration is mediated by CD44-dependent TGF beta activation. J Cell Sci. 121:1393–1402. 2008. View Article : Google Scholar : PubMed/NCBI
48	Halem-Smith H, Calderon R, Song Y, Tuan RS and Chen FH: Cartilage oligomerix matrix protein enhances matrix assembly during chondrogenesis of human mesenchymal stem cells. J Cell Biochem. 113:1245–1252. 2012. View Article : Google Scholar : PubMed/NCBI
49	Tseng S, Reddi AH and Di Cesare PE: Cartilage oligomeric matrix protein (COMP): A biomeraker of arthritis. Biomark Insights. 4:33–44. 2009.PubMed/NCBI
50	Ghert MA, Qi WN, Erickson HP, Block JA and Scully SP: Tenascin-C expression and distribution in cultured human chondrocytes and chondrosarcoma cells. J Orthop Res. 20:834–841. 2002. View Article : Google Scholar : PubMed/NCBI
51	Murphy LI, Fischer D, Chiquet-Ehrismann R and Mackie EJ: Tenascin-C induced stimulation of chondrogenesis is dependent on the presence of the C-terminal fibrinogen-like globular domain. FEBS Lett. 480:189–192. 2000. View Article : Google Scholar : PubMed/NCBI
52	Trebaul A, Chan EK and Midwood KS: Regulation of fibroblast migration by tenascin-C. BiochemSoc Trans. 35:695–697. 2007. View Article : Google Scholar
53	Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S and Ishige N: Involvement of the Wnt signaling pathway in feeder-free culture of human induced pluripotent stem cells. Mol Med Rep. 12:6797–6800. 2015.PubMed/NCBI
54	Qiu D, Ye S, Ruiz B, Zhou X, Liu D, Zhang Q and Ying QL: Klf2 and Tfcp2l1, Two Wnt/β-catenin targets, act synergistically to induce and maintain naive pluripotency. Stem Cell Reports. 5:314–322. 2015. View Article : Google Scholar : PubMed/NCBI
55	Marucci L, Pedone E, Di Vicino U, Sanuy-Escribano B, Isalan M and Cosma MP: β-catenin fluctuates in mouse ESCs and is essential for Nanog-mediated reprogramming of somatic cells to pluripotency. Cell Rep. 8:1686–1696. 2014. View Article : Google Scholar : PubMed/NCBI
56	Davidson KC, Adams AM, Goodson JM, McDonald CE, Potter JC, Berndt JD, Biechele TL, Taylor RJ and Moon RT: Wnt/β-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4. Proc Natl Acad Sci USA. 109:4485–4490. 2012. View Article : Google Scholar : PubMed/NCBI
57	Modarresi R, Lafond T, Roman-Blas JA, Danielson KG, Tuan RS and Seghatoleslami MR: N-cadherin mediated distribution of beta-catenin alters MAP kinase and BMP-2 signaling on chondrogenesis-related gene expression. J Cell Biochem. 95:53–63. 2005. View Article : Google Scholar : PubMed/NCBI
58	Huang Y, Zhang X, Du K, Yang F, Shi Y, Huang J, Tang T, Chen D and Dai K: Inhibition of β-catenin signaling in chondrocytes induces delayed fracture healing in mice. J Orthop Res. 30:304–310. 2012. View Article : Google Scholar : PubMed/NCBI
59	Li TF, Chen D, Wu Q, Chen M, Sheu TJ, Schwarz EM, Drissi H, Zuscik M and O'Keefe RJ: Transforming growth factor-beta stimulates cyclin D1 expression through activation of beta-catenin signaling in chondrocytes. J BiolChem. 281:21296–21304. 2006.